Sanofi and IGM Biosciences team up to develop antibody agonists
Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval
Read Moreby John Pinching | Mar 29, 2022 | News | 0
Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval
Read Moreby Selina McKee | Sep 4, 2020 | News | 0
The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major human diseases
Read Moreby Selina McKee | Apr 17, 2020 | News | 0
The test could help indicate if a person has gained immunity against the virus and inform treatment decisions
Read Moreby Selina McKee | Aug 3, 2017 | News | 0
The Medical Research Council and UCB have launched a new scheme designed to help accelerate work on the development of antibody-based therapeutics.
Read Moreby Selina McKee | Nov 9, 2016 | News | 0
MRC Technology, Belgian drugmaker UCB and the University of Leicester have set up a new research consortium focusing on antibody-assisted structure-based drug discovery.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479